More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

To date Mesa received $4.5 million in One Arizona settlement funds. The city will give $1 million to nonprofits working to ...

Vertex Pharmaceuticals Inc. gained US approval for the first new type of painkiller in more than two decades, paving the way ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...